(I) US FDA ANDA PREPARATION OF SOLID ORAL TABLETS 200 MG OF DRUG X, USP (II) INVESTIGATION OF DISSOLUTION PARAMETERS DUR

Zapisane w:

Opis bibliograficzny
1. autor:	PHADNIS SUDHIKSHA
Format:	Książka
Wydane:
Hasła przedmiotowe:
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy

A. ANDA PREPARATION FOR SOLID ORAL TABLETS OF DRUG 'X' B. VALIDATION OF DISSOLUTION METHOD FOR SOLID TABLETS OF DRUG 'Y'
od: BHAVNANI KAMLESH

1. LINE EXTENSION OF THE EXISTING USFDA-ANDA FOR AN ANTI HYPERTENSIVE EXTENDED TABLETS USP, 25 MG AND 2. VALIDATION OF D
od: DIVEKAR RUCHA

Dur: Kshitigapalikadale
od: Londhe, Laxman
Wydane: (2002)

Dur Gaganke tare
od: Paradeshi, Pran
Wydane: (1963)

Dur Gaganke tare
od: Paradeshi, Pran
Wydane: (1963)

1) PREPARATION AND SUBMISSION OF ANDA FOR XYZ TABLET TO USFDA 2) DISSOLUTION METHOD VALIDATION FOR DRUG XYZ, CALIBRATION
od: PANDEY SHAILESH

BIOEQUIVALENCE STUDY OF OXCARBAZEPINE TABLETS (600 mg) WITH TRILEPTAL (OXCARBAZEPINE) TABLETS (600 mg) IN ADULT, HUMAN S
od: KHAN TANVEER

Drug dissolution testing of oral dosage forms
od: Vaidya Rohit Sudhir

BIOEQUIVALENCE STUDY OF PRASUGREL 10 mg TABLETS
od: PARMAR GIRISH

DUR DESH KI GANDH
od: MEHTA, SATISH
Wydane: (2012)

DUR DESH KI GANDH
od: MEHTA, SATISH
Wydane: (2012)

Rahile dur ghar majhe
od: Khan, S
Wydane: (2015)

Rahile dur ghar majhe
od: Khan, S
Wydane: (2015)

"Part I - Regulatory Framework for the Novel Polymers and Features of Approved Polymers in Orally Disintegrating Tablets as per U.S. FDA Part II - Preparation of Module 3 for the Submission of ANDA in the U.S. Market at Bliss GVS Pharma Ltd"
od: Shetty Kavyashree

BIOEQUIVALENCE STUDY OF SINGLE DOSE FAMCICLOVIR TABLETS 500 mg COMPARING WITH FAMVIR (FAMCICLOVIR) TABLETS 500 mg IN HEA
od: JAIN PANKAJ

Inventory Parameters
od: Sharma,Sanjay
Wydane: (2017)

Formulation Development of Artemether and Lumefantrine for Improvement of Solubility and Dissolution Rate for Oral Drug Delivery (Tablet)
od: Rohit Patel
Wydane: (2017)

PREPARATION OF ABBREVIATED NEW DRUG APPLICATION FOR US MARKET, AMOXICILLIN CAPSULES USP, 500 mg
od: DUBEY PRAKHAR

DEVELOPLMENT AND BIOEQUIVALENCE STUDY OF OLANZAPINE 10 mg TABLET
od: WAYKAR RAVINDRA

FORMULATION OF ARIPIPRAZOLE ORALLY DISINTEGRATING TABLETS
od: AGARWAL PRATEEK

FDA REGULATORY AFFAIRS
od: MANTUS DAVID; PISANO DOUGLAS
Wydane: (2017)

FDA REGULATORY AFFAIRS
od: MANTUS DAVID
Wydane: (2021)

FDA REGULATORY AFFAIRS
od: PISANO DOUGLAS J
Wydane: (2004)

FDA regulatory affairs
od: Mantus.David
Wydane: (2014)

BIOEQUIVALENCE STUDY OF SINGLE DOSE DRONEDARONE TABLET 400 mg WITH MULTAQ 400 mg WITH MULATAQ 400 mg UNDER FAST CONDITIO
od: PATIL SATISH

FORMULATION AND DEVELOPMENT OF MODIFIED RELEASE DOSAGE FORM CONTAINING METFORMIN HYDROCHLORIDE 500 Mg AS AN ANDA PERSPEC
od: CHINCHOLE AMOL

BIOEQUIVALENCE STUDY OF A SINGLE DOSE OF VORICONAZOLE TABLETS 200 MG IN ADULT HUMAN SUBJECTS UNDER FASTING CONDITIONS
od: PATEL PARMI

METHOD DEVELOPMENT AND VALIDATION OF ASSAY AND DISSOLUTION FOR ETORICOXIB TABLETS
od: THUMAR RUTU

FORMULATION AND EVALUATION OF PARACETAMOL 325 MG + CAFFEINE 50 MG FAST ACTING IMMIDIATE RELEASE TABLETS
od: SHARMA AKSHAT

FORMULATION DEVELOPMENT OF FELODIPINE PROLONGED RELEASE TABLETS 10 MG
od: MANDPE PANKAJ

PROCESS VALIDATION OF IMMUNOSUPRESSANT FILM COATED TABLET 50 mg
od: GAJERA JAGDISHKUMAR

FORMULATION, DEVELOPMENT AND EVALUATION OF ORALLY DISINTEGRATING TABLET
od: JAIN MEETA

FORMULATION DEVELOPMENT AND EVALUATION OF ORAL CONTRACEPTIVE TABLET
od: SHAIKH MUSA

FORMULATION AND EVALUATION OF OLANZAPINE ORALLY DISINTEGRATING TABLET
od: PATEL RIKIN

Development and Characterization of Danazol Orally Disintegrating Tablets
od: Yennawar Rohit

BIOAVAILABILITY AND BIOEQUIVALENCE STUDY OF AMOXYCILLIN 875 MG AND CLAVULANIC ACID 125 MG TABLET UNDER FED CONDITION ON
od: TRANGADIYA NIDHI

ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF DRUG X, ASSAY, DISSOLUTION AND RELTED SUBSTANCE TEST AS PER US FDA REQUI
od: SAWARDEKAR POOJA

FDA ADMINISTRATIVE ENFORCEMENT MANUAL
od: PARKER FLORENCE R [A]
Wydane: (2005)

METHOD DEVELOPMENT AND VALIDATION FOR DISSOLUTION TEST OF THE TABLET CONTAINING QUETIAPINE
od: AWASTHI YOGESH

STABILITY STUDY OF NTP FILM COATED TABLETS 2.5 mg
od: PANDYA MALAYKUMAR